文献速递神经肿瘤脑血管病外科

ELTD1缺失减少胶质瘤血管异常并改善PD-1阻断后T细胞募集

ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
PubMed 文献 · Neuro Oncol · 2022-01-01

该研究利用组织芯片和公共数据库分析人胶质瘤中ELTD1表达与生存的关系,并用原位胶质瘤模型和ELTD1-/-小鼠探讨其对肿瘤血管表型的调控。结果显示ELTD1在胶质瘤血管中上调、随恶性程度增加并与不良生存相关;ELTD1缺失虽不影响肿瘤进展,但改善血管功能并增强PD-1阻断后T细胞浸润。

要点

  • ELTD1在胶质瘤血管中上调,随恶性程度增加,与患者不良生存相关。
  • ELTD1缺失不影响原位胶质瘤进展,但改善肿瘤血管功能。
  • ELTD1缺失增强PD-1阻断后GL261荷瘤小鼠的T细胞浸润。

核心结论

  • ELTD1参与诱导胶质瘤血管功能障碍,靶向ELTD1可能使血管正常化并改善免疫治疗反应。

研究设计与样本

  • 研究采用组织芯片和公共数据库分析人胶质瘤ELTD1表达与生存关联。
  • 使用原位胶质瘤模型和ELTD1-/-小鼠分析ELTD1对肿瘤血管表型的调控。
  • 对小鼠胶质瘤来源内皮细胞进行转录谱分析以确定差异表达基因和通路。
  • 对荷瘤小鼠给予PD-1阻断抗体以评估ELTD1缺失对胶质瘤免疫的影响。

主要发现

  • ELTD1在人胶质瘤血管中表达上调,随肿瘤恶性程度增加,并与患者不良生存相关。
  • ELTD1缺失不影响原位胶质瘤进展,但ELTD1-/-小鼠肿瘤血管功能改善。
  • 差异表达基因生物信息学分析提示ELTD1-/-小鼠肿瘤内皮炎症反应增加、增殖降低。
  • ELTD1缺失改善GL261荷瘤小鼠在PD-1检查点阻断后的T细胞浸润。

临床怎么用

  • ELTD1可作为胶质瘤血管正常化和免疫联合治疗的潜在靶点。
  • 靶向ELTD1可能改善PD-1阻断治疗中T细胞向肿瘤的浸润。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumor vessels in glioma are molecularly and functionally abnormal, contributing to treatment resistance. Proteins differentially expressed in glioma vessels can change vessel phenotype and be targeted for therapy. ELTD1 (Adgrl4) is an orphan member of the adhesion G-protein-coupled receptor family upregulated in glioma vessels and has been suggested as a potential therapeutic target. However, the role of ELTD1 in regulating vessel function in glioblastoma is poorly understood. METHODS: ELTD1 expression in human gliomas and its association with patient survival was determined using tissue microarrays and public databases. The role of ELTD1 in regulating tumor vessel phenotype was analyzed using orthotopic glioma models and ELTD1-/- mice. Endothelial cells isolated from murine gliomas were transcriptionally profiled to determine differentially expressed genes and pathways. The consequence of ELTD1 deletion on glioma immunity was determined by treating tumor-bearing mice with PD-1-blocking antibodies. RESULTS: ELTD1 levels were upregulated in human glioma vessels, increased with tumor malignancy, and were associated with poor patient survival. Progression of orthotopic gliomas was not affected by ELTD1 deletion, however, tumor vascular function was improved in ELTD1-/- mice. Bioinformatic analysis of differentially expressed genes indicated increased inflammatory response and decreased proliferation in tumor endothelium in ELTD1-/- mice. Consistent with an enhanced inflammatory response, ELTD1 deletion improved T-cell infiltration in GL261-bearing mice after PD-1 checkpoint blockade. CONCLUSION: Our data demonstrate that ELTD1 participates in inducing vascular dysfunction in glioma, and suggest that targeting of ELTD1 may normalize the vessels and improve the response to immunotherapy.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Huang H, Georganaki M, Conze LL, et al. ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma. Neuro Oncol. 2022. PMID: 34347079. doi:10.1093/neuonc/noab181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。